This report provides comprehensive coverage of the major GIT markets, incorporating a detailed epidemiological analysis of the major indications and key factors impacting their prevalence; using IMS data, it provides analysis of current leading brands of treatment within each GIT indication provides an invaluable insight into the dynamics of the market, while profiling the pharmaceutical companies and relevant market trends that influence the sales of GIT treatments. This report further provides forecasts of major products over the 2005-10 period and the underlying trends affecting the future of the GIT market. By providing coverage of over 90% of the total market for GIT products and highlighting key players, this report allows the reader to gain a thorough understanding of the issues that are driving the transformation of the GIT market, and understand the likely direction that this market will take over the next 5 years.
